| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 5,801 | 7,688 | ||
| Restricted cash | 280 | 150 | ||
| Marketable securities | 73,867 | 84,135 | ||
| Prepaid expenses and other current assets | 4,220 | 3,317 | ||
| Assets held for sale | 112,096 | 112,096 | ||
| Total current assets | 196,264 | 207,386 | ||
| Property, plant and equipment, net | 138 | 150 | ||
| Operating lease right-of-use assets | 415 | 590 | ||
| Long-term investments | 3,444 | 11,659 | ||
| Accrued rent receivable | 7,360 | - | ||
| Other long-term assets | 4,147 | 11,201 | ||
| Total assets | 211,768 | 230,986 | ||
| Accounts payable | 928 | 523 | ||
| Accrued expenses and other current liabilities | 4,769 | 13,329 | ||
| Total current liabilities | 5,697 | 13,852 | ||
| Contingent consideration | 948 | 948 | ||
| Operating lease liabilities, non-current | 0 | 6 | ||
| Loan payable | 84,613 | 84,420 | ||
| Other long-term liabilities | 88 | 90 | ||
| Total liabilities | 91,346 | 99,316 | ||
| Additional paid-in capital | 839,331 | 837,185 | ||
| Accumulated other comprehensive loss | -612 | -805 | ||
| Accumulated deficit | -718,297 | -704,710 | ||
| Total stockholders equity | 120,422 | 131,670 | ||
| Total liabilities and stockholders equity | 211,768 | 230,986 | ||
Instil Bio, Inc. (TIL)
Instil Bio, Inc. (TIL)